Mikhail V. Blagosklonny
Medicine Branch
National Cancer Institute
NIH, Bethesda
MD 20892
USA
Name/email consistency: high
- P53: an ubiquitous target of anticancer drugs. Blagosklonny, M.V. Int. J. Cancer (2002)
- Basic cell cycle and cancer research: is harmony impossible?. Blagosklonny, M.V. Cell. Cycle (2002)
- Inhibition of transcription results in accumulation of Wt p53 followed by delayed outburst of p53-inducible proteins: p53 as a sensor of transcriptional integrity. Blagosklonny, M.V., Demidenko, Z.N., Fojo, T. Cell. Cycle (2002)
- Resistance to growth inhibitory and apoptotic effects of phorbol ester and UCN-01 in aggressive cancer cell lines. Blagosklonny, M.V., Dixon, S.C., Robey, R., Figg, W.D. Int. J. Oncol. (2001)
- Inhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions. Blagosklonny, M.V., Giannakakou, P., Romanova, L.Y., Ryan, K.M., Vousden, K.H., Fojo, T. Carcinogenesis (2001)
- Exploiting cancer cell cycling for selective protection of normal cells. Blagosklonny, M.V., Pardee, A.B. Cancer Res. (2001)
- Hypoxia-inducible factor: Achilles' heel of antiangiogenic cancer therapy (review). Blagosklonny, M.V. Int. J. Oncol. (2001)
- How carcinogens (or telomere dysfunction) induce genetic instability: associated-selection model. Blagosklonny, M.V. FEBS Lett. (2001)
- Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs. Blagosklonny, M.V., Robey, R., Bates, S., Fojo, T. J. Clin. Invest. (2000)
- Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cells. Blagosklonny, M.V., Bishop, P.C., Robey, R., Fojo, T., Bates, S.E. Cancer Res. (2000)
- p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect. Blagosklonny, M.V. FASEB J. (2000)
- A node between proliferation, apoptosis, and growth arrest. Blagosklonny, M.V. Bioessays (1999)
- Molecular effects of paclitaxel: myths and reality (a critical review). Blagosklonny, M.V., Fojo, T. Int. J. Cancer (1999)
- Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells. Blagosklonny, M.V., El-Deiry, W.S. Int. J. Cancer (1998)
- Like p53, the proliferation-associated protein p120 accumulates in human cancer cells following exposure to anticancer drugs. Blagosklonny, M.V., Iglesias, A., Zhan, Z., Fojo, T. Biochem. Biophys. Res. Commun. (1998)
- p53 inhibits hypoxia-inducible factor-stimulated transcription. Blagosklonny, M.V., An, W.G., Romanova, L.Y., Trepel, J., Fojo, T., Neckers, L. J. Biol. Chem. (1998)
- The mitogen-activated protein kinase pathway mediates growth arrest or E1A-dependent apoptosis in SKBR3 human breast cancer cells. Blagosklonny, M.V. Int. J. Cancer (1998)